Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 11

1.
2.

Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications.

Nazha A, Khoury JD, Rampal RK, Daver N.

Oncologist. 2015 Oct;20(10):1154-60. doi: 10.1634/theoncologist.2015-0094. Epub 2015 Aug 24.

PMID:
26304912
3.

The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms.

Yonal-Hindilerden I, Daglar-Aday A, Akadam-Teker B, Yilmaz C, Nalcaci M, Yavuz AS, Sargin D.

J Clin Med Res. 2015 Mar;7(3):161-70. doi: 10.14740/jocmr2047w. Epub 2014 Dec 29.

4.

Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia.

Daver N, Shastri A, Kadia T, Newberry K, Pemmaraju N, Jabbour E, Zhou L, Pierce S, Cortes J, Kantarjian H, Verstovsek S.

Leuk Res. 2014 Sep;38(9):1126-9. doi: 10.1016/j.leukres.2014.06.015. Epub 2014 Jul 6.

5.

Therapy with the histone deacetylase inhibitor pracinostat for patients with myelofibrosis.

Quintás-Cardama A, Kantarjian H, Estrov Z, Borthakur G, Cortes J, Verstovsek S.

Leuk Res. 2012 Sep;36(9):1124-7. doi: 10.1016/j.leukres.2012.03.003. Epub 2012 Apr 2.

6.

Off-pump coronary artery surgery in a patient with essential thrombocythaemia: two life-threatening complications in the same patient.

Kaya K, Cavolli R, Telli A, Tasoz R.

BMJ Case Rep. 2009;2009. pii: bcr01.2009.1503. doi: 10.1136/bcr.01.2009.1503. Epub 2009 Aug 25.

7.

Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Teixeira AR, Hecht MM, Guimaro MC, Sousa AO, Nitz N.

Clin Microbiol Rev. 2011 Jul;24(3):592-630. doi: 10.1128/CMR.00063-10. Review.

8.

Trypanosoma cruzi in the chicken model: Chagas-like heart disease in the absence of parasitism.

Teixeira AR, Gomes C, Nitz N, Sousa AO, Alves RM, Guimaro MC, Cordeiro C, Bernal FM, Rosa AC, Hejnar J, Leonardecz E, Hecht MM.

PLoS Negl Trop Dis. 2011 Mar 29;5(3):e1000. doi: 10.1371/journal.pntd.0001000.

9.

Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor.

Quintás-Cardama A, Manshouri T, Estrov Z, Harris D, Zhang Y, Gaikwad A, Kantarjian HM, Verstovsek S.

Invest New Drugs. 2011 Oct;29(5):818-26. doi: 10.1007/s10637-010-9429-z. Epub 2010 Apr 7.

10.

In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele.

Gaikwad A, Nussenzveig R, Liu E, Gottshalk S, Chang K, Prchal JT.

Exp Hematol. 2007 Apr;35(4):587-95.

11.

The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.

Jamieson CH, Gotlib J, Durocher JA, Chao MP, Mariappan MR, Lay M, Jones C, Zehnder JL, Lilleberg SL, Weissman IL.

Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6224-9. Epub 2006 Apr 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk